Assessing the impact of a safe and equitable biosimilar policy in the United States
Subtitle: hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007.
Publisher: U.S. G.P.O.; For sale by the Supt. of Docs., U.S. G.P.O.
Published: 2008
Place of publication: Washington
Language: eng
Number of pages: 184
ISBN-13: 9780160808876
Subjects: Biologicals -- United States.; Pharmaceutical biotechnology -- United States.; Generic drugs -- United States.
Notes: Distributed to some depository libraries in microfiche.

Shipping list no. unavailable.

"Serial no. 110-40."

Includes bibliographical references.

Also available via Internet from the GPO Access web site. Address as of 5/14/08: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110%5Fhouse%5Fhearings&docid=f:40500.pdf; current access available via PURL.